Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

CMOs Target Parenteral Drug Development Needs Both Large and Small

August 1, 2014
Pharmaceutical Technology

Representatives of contract service organizations that specialize in parenteral drug development and manufacturing describe the evolving trends.

Outsourcing Grows in Europe

August 1, 2014

Pharmaceutical Technology Europe

Eric Langer of BioPlan Associates describes the development of biopharmaceutical outsourcing in Europe over the past 25 years.

Weighing Clinical Trial Outsourcing Options

August 1, 2014

Pharmaceutical Technology

Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.

Europe's Need for Early Development Pharmaceutical Manufacturing Expertise

August 1, 2014

Pharmaceutical Technology

Despite the growth of specialist companies with capabilities across various therapeutic areas in Europe, there is still a need for early development expertise with end-to-end pharmaceutical manufacturing capabilities.

Shifting Gears in Drug Development Outsourcing Responsibilities

August 1, 2014

Pharmaceutical Technology

For a bio/pharma industry in flux, contract services are playing a greater—and more diverse—role in drug development.

Analytical Labs Strive to Deliver More Information, Faster

August 1, 2014
Pharmaceutical Technology

Experts from contract testing laboratories and service organizations shared their perceptions of analytical testing advances, and challenges still ahead.

Health Systems Raise the Bar on Reimbursing New Drugs

July 2, 2014

Pharmaceutical Technology

As payers refuse to cover new drugs, CMOs take a hit.

Pharma Capacity to Produce Cytotoxic Injectable Drugs Constricts

June 29, 2014
PTSM: Pharmaceutical Technology Sourcing and Management

PharmSource special report shows demand for cytotoxic injectable drugs could tap existing CMO capacity.

Outsourcing No Longer Just for Cost-Cutting

June 2, 2014

Pharmaceutical Technology

With budgets growing, clients see CMOs' costs as less crucial.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here